PD15-10 WHICH PATIENT WITH BIOCHEMICAL RECURRENCE AFTER PRIMARY TREATMENT FOR PROSTATE CANCER WOULD RESULT IN A POSITIVE 68GA-PSMA PET/CT? A CLINICAL TOOL TO GUIDE PHYSICIANS BEFORE SUGGESTING 68GA-PSMA PET/CT

L. Bianchi,Francesco Ceci,Marco Borghesi,Giulia Polverari,Federico Mineo Bianchi,U. Barbaresi,F. Chessa,Paolo Castellucci,Riccardo Schiavina,Stefano Fanti,Eugenio Brunocilla

PD15-10 WHICH PATIENT WITH BIOCHEMICAL RECURRENCE AFTER PRIMARY TREATMENT FOR PROSTATE CANCER WOULD RESULT IN A POSITIVE 68GA-PSMA PET/CT? A CLINICAL TOOL TO GUIDE PHYSICIANS BEFORE SUGGESTING 68GA-PSMA PET/CT

2019

L. Bianchi
Francesco Ceci
Marco Borghesi
Giulia Polverari
Federico Mineo Bianchi
U. Barbaresi
F. Chessa
Paolo Castellucci
Riccardo Schiavina
Stefano Fanti
Eugenio Brunocilla

INTRODUCTION AND OBJECTIVES:To develop a clinical nomogram aimed to predict which patients with recurrent prostate cancer (PCa) could benefit from 68Gallium-Prostate Specific Membrane Antigen Posit...

Keywords:

Urology
Radiology
Prostate cancer
PET-CT
Biochemical recurrence
Medicine
Recurrent prostate cancer
68ga psma
Nomogram
membrane antigen
primary treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations